Arvaya Healthcare524723Preferential allotment
Board approves allotment of ~38.72 lakh equity shares at Rs.40 on a share swap basis
Board of Arvaya Healthcare met on 24 October 2026 and approved an allotment of equity shares.
By ScoutQuest · · 2 min read
₹40/-Issue price per equity share
Premium per equity share₹30/-
Face value per equity share₹10/-
- Shares allotted
- ~38.72 lakh equity shares of face value Rs.10 each
- Issue price
- Rs.40 per share (premium Rs.30)
- Total consideration
- ~Rs.15.49 crore
What the board approved
- The Board of Directors, at its meeting on 24 October 2026, approved the allotment of ~38.72 lakh fully paid-up equity shares of face value of Rs.10 each.
- Issue price is Rs.40 per equity share, including a premium of Rs.30 per share.
- The total amount aggregates to ~Rs.15.49 crore.
- The allotment is on a preferential basis through a private placement, for consideration other than cash, on a share swap basis.
- The shares go to shareholders of Sushodha Institute of Gastroenterology Private Limited (SIGPL).
- All 47 allottees are listed under the Non-Promoter category.
Share capital before and after
- Paid-up equity capital before the allotment: ~Rs.48.02 crore, consisting of ~4.8 crore equity shares of Rs.10 each.
- Paid-up equity capital after the allotment: ~Rs.51.89 crore, consisting of ~5.19 crore equity shares of Rs.10 each.
- The new equity shares rank pari-passu with the existing equity shares in all respects.
How the transaction was cleared
- The proposal was considered at the Board Meeting held on Saturday, July 11, 2026.
- Shareholders approved it through a postal ballot dated 13 August 2026.
- In-Principle Approval was received from BSE Limited vide Letter No. LOD/PREF/KS/FIP/920/2026-27 dated October 12, 2026.
What happens next
- The equity shares allotted on a preferential basis are locked-in for a specified period in compliance with Chapter VII of the ICDR Regulations, 2018.
- The company will apply to the stock exchanges for listing and trading approval for the newly allotted shares in due course.
What this means for a retail investor
- This is an issuance of fresh shares to a set of incoming shareholders, settled by swapping shares rather than by paying cash to the company.
- The total number of shares in issue rises from 4,80,21,857 to 5,18,93,711, so each existing share now represents a smaller slice of the company.
- The price of Rs.40 per share, and the fact that the new shares carry the same rights as existing shares, are the two figures to note when judging the terms of the issuance.
Also from Arvaya Healthcare
Executive Director allotted ~5.91 lakh equity shares on preferential basis
24 Oct 2026
Allotment of ~38.72 lakh equity shares at Rs.40 each on a share-swap basis
24 Oct 2026
Board meeting on 24 October 2026 to consider allotment of ~38.72 lakh equity shares to SIGPL shareholders
17 Oct 2026
More numbers
- Equity shares allotted38,71,854
- Issue price per equity share₹40/-
- Face value per equity share₹10/-
- Premium per equity share₹30/-
- Total allotment amount₹15,48,74,160/-
- Paid-up equity capital after allotmentRs. 51,89,37,110/-
- Total equity shares after allotment5,18,93,711
- Number of investors allotted shares47
Source: BSE · 24 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.